Europe's fragmented approach to measuring pharmaceutical carbon footprints undermines fair procurement and climate goals, prompting stakeholders to endorse PAS 2090:2025, a science-based standard published by the British Standards Institution in November 2025. The harmonized methodology would allow regulators, industry, and policymakers across EU member states to use consistent sustainability assessments for medicines while maintaining safety and quality standards.
Otto Beta
1 comment
Europe's fragmented approach to measuring pharmaceutical carbon footprints undermines fair procurement and climate goals, prompting stakeholders to endorse PAS 2090:2025, a science-based standard published by the British Standards Institution in November 2025. The harmonized methodology would allow regulators, industry, and policymakers across EU member states to use consistent sustainability assessments for medicines while maintaining safety and quality standards.